摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3α,5α)-3-hydroxy-11-oxoandrost-16-ene-17-carbonitrile | 1258041-13-2

中文名称
——
中文别名
——
英文名称
(3α,5α)-3-hydroxy-11-oxoandrost-16-ene-17-carbonitrile
英文别名
(3R,5S,8S,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-11-oxo-1,2,3,4,5,6,7,8,9,12,14,15-dodecahydrocyclopenta[a]phenanthrene-17-carbonitrile
(3α,5α)-3-hydroxy-11-oxoandrost-16-ene-17-carbonitrile化学式
CAS
1258041-13-2
化学式
C20H27NO2
mdl
——
分子量
313.44
InChiKey
NQFWHWPKEITVRR-WTJPMNHOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    23
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    61.1
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3α,5α)-3-hydroxy-11-oxoandrost-16-ene-17-carbonitrile 在 5% Pd(II)/C(eggshell) 、 氢气 作用下, 以 乙酸乙酯 为溶剂, 反应 3.0h, 以30 mg的产率得到(3α,5α,17β)-3-hydroxy-11-oxoandrostane-17-carbonitrile
    参考文献:
    名称:
    Neurosteroid analogues. 15. A comparative study of the anesthetic and GABAergic actions of alphaxalone, Δ16-alphaxalone and their corresponding 17-carbonitrile analogues
    摘要:
    Alphaxalone, a neuroactive steroid containing a 17 beta-acetyl group, has potent anesthetic activity in humans. This pharmacological activity is attributed to this steroid's enhancement of gamma-amino butyric acid-mediated chloride currents at gamma-amino butyric acid type A receptors. The conversion of alphaxalone into Delta(16)-alphaxalone produces an analogue that lacks anesthetic activity in humans and that has greatly diminished receptor actions. By contrast, the corresponding 17 beta-carbonitrile analogue of alphaxalone and the Delta(16)-17-carbonitrile analogue both have potent anesthetic and receptor actions. The differential effect of the Delta(16)-double bond on the actions of alphaxalone and the 17 beta-carbonitrile analogue is accounted for by a differential effect on the orientation of the 17-acetyl and 17-carbonitrile substituents. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.09.008
  • 作为产物:
    描述:
    (3α,5α)-3-(methyloxymethyl)oxy-11-oxoandrost-16-ene-17-carbonitrile盐酸 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 4.0h, 以93%的产率得到(3α,5α)-3-hydroxy-11-oxoandrost-16-ene-17-carbonitrile
    参考文献:
    名称:
    Neurosteroid analogues. 15. A comparative study of the anesthetic and GABAergic actions of alphaxalone, Δ16-alphaxalone and their corresponding 17-carbonitrile analogues
    摘要:
    Alphaxalone, a neuroactive steroid containing a 17 beta-acetyl group, has potent anesthetic activity in humans. This pharmacological activity is attributed to this steroid's enhancement of gamma-amino butyric acid-mediated chloride currents at gamma-amino butyric acid type A receptors. The conversion of alphaxalone into Delta(16)-alphaxalone produces an analogue that lacks anesthetic activity in humans and that has greatly diminished receptor actions. By contrast, the corresponding 17 beta-carbonitrile analogue of alphaxalone and the Delta(16)-17-carbonitrile analogue both have potent anesthetic and receptor actions. The differential effect of the Delta(16)-double bond on the actions of alphaxalone and the 17 beta-carbonitrile analogue is accounted for by a differential effect on the orientation of the 17-acetyl and 17-carbonitrile substituents. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.09.008
点击查看最新优质反应信息

文献信息

  • NEUROACTIVE 17(20)-Z-VINYLCYANO-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
    申请人:Covey Douglas
    公开号:US20140309443A1
    公开(公告)日:2014-10-16
    The present disclosure is generally directed to neuroactive 17(20)-Z-vinylcyano-substituted compound of Formula (I) and (II), as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to GABA function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds.
    本公开涉及一般指向化合物的神经活性17(20)-Z-乙烯基基取代物,其化学式为(I)和(II),并且其药学上可接受的盐,例如用作麻醉剂,和/或用于治疗与GABA功能和活性相关的疾病。本公开还涉及包含这种化合物的药物组合物。
  • US9388210B2
    申请人:——
    公开号:US9388210B2
    公开(公告)日:2016-07-12
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B